Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
ConditionPregnant Women
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1/PlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Gestational age ≥ 32 weeks
Obtaining informed consent for participation in the study and for the processing of personal data
Pregnant patients with an indication to perform placental marker testing as part of routine clinical practice
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov